AlphaOnco’s patent portfolio ranked as the fourth largest in terms of number of patent submitted in Nanomedicine by Mark and Clerk.
- the methods of treatment using various sources of magnetosomes excitation;
- magnetosome-based products;
- magnetosome production processes.
Use of at least one chelating agent introduced into the culture medium of magnetotactic bacteria in order to stimulate the growth thereof, int. publ. number: WO2012/153247, first priority FR1153938 filed on 06/05/2011, inventors: E. Alphandéry, I. Chebbi.
Cellular production of pure iron oxide nanoparticles, first priority FR1801034 submitted on 02/10/2018, inventor: E. Alphandéry.
Method for removing impurities from nanoparticles, first priorities FR20180001033 and FR20180001034 submitted on 02/10/2018, inventor: E.Alphandéry.
